Advertisement

Journal of Community Health

, Volume 40, Issue 4, pp 619–624 | Cite as

HBV Outreach Programs Significantly Increase Knowledge and Vaccination Rates Among Asian Pacific Islanders

  • Tresa Zacharias
  • Winnie Wang
  • Doan Dao
  • Helena Wojciechowski
  • William M. Lee
  • Son Do
  • Amit G. Singal
Original Paper

Abstract

Hepatitis B virus (HBV) testing and vaccination rates remain low among Asian-American/Pacific Islanders (APIs) despite high rates of HBV infection. The aim of our study was to assess the effectiveness of an outreach campaign to increase HBV knowledge, testing, and vaccination among a cohort of APIs. Vietnamese Americans were invited to participate in a free HBV screening and vaccination outreach program though pubic service announcements. Attendees completed a survey to assess barriers to vaccination and HBV-related knowledge before and after a 30-min education session by a bilingual board-certified gastroenterologist. Among 98 participants, 100 % (22/22) of HBV naïve patients were provided a HBV vaccination series at no cost and over 75 % (14/18) of HBV-infected patients were connected to further medical care. Notable reported barriers to prior testing and/or vaccination were cost of the vaccine, concern about missing work for evaluation, and lack of provider recommendation. Knowledge levels about HBV risk factors, potential consequences, and treatment options were poor at baseline but significantly increased after the education session (49 vs. 64 %, p < 0.001). Outreach campaigns linked with education can successfully address several barriers to HBV testing and offer an approach to improve HBV awareness and prevention among difficult-to-reach populations.

Keywords

Hepatitis B Outreach Vaccination Prevention Education 

Notes

Acknowledgments

Albert Ho Dao, Jeffrey Dinh, Khoan Vu, Varun Shah, and staff at Saigon Mall. This work was conducted with support from the National Center for Translational Medicine, of the National Institutes of Health under award KL2TR001103 awarded to Dr. Singal, the Morton Meyerson Private Foundation, the National Asian Pacific Islander American Medical Student Association, and anonymous philanthropy. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Conflict of interest

None of the authors have any personal interests relevant to this manuscript to declare

References

  1. 1.
    Tong, M. J., Pan, C. Q., Hann, H. W., et al. (2011). The management of chronic hepatitis B in Asian Americans. Digestive Diseases and Sciences, 56, 3143–3162.PubMedCrossRefGoogle Scholar
  2. 2.
    Kowdley, K. V., Wang, C. C., Welch, S., et al. (2012). Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology, 56, 422–433.PubMedCrossRefGoogle Scholar
  3. 3.
    Ha, N. B., Trinh, H. N., Nguyen, T. T., et al. (2013). Prevalence, risk factors, and disease knowledge of chronic hepatitis B infection in Vietnamese Americans in California. Journal of Cancer Education, 28, 319–324.PubMedCrossRefGoogle Scholar
  4. 4.
    Ma, G. X., Shive, S. E., Fang, C. Y., et al. (2007). Knowledge, attitudes, and behaviors of hepatitis B screening and vaccination and liver cancer risks among Vietnamese Americans. Journal of Health Care for the Poor and Underserved, 18, 62–73.PubMedCrossRefGoogle Scholar
  5. 5.
    Taylor, V. M., Choe, J. H., Yasui, Y., et al. (2005). Hepatitis B awareness, testing, and knowledge among Vietnamese American men and women. Journal of Community Health, 30, 477–490.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Thompson, M. J., Taylor, V. M., Jackson, J. C., et al. (2002). Hepatitis B knowledge and practices among Chinese American women in Seattle, Washington. J Cancer Educ, 17, 222–226.PubMedGoogle Scholar
  7. 7.
    Cohen, C., Holmberg, S. D., McMahon, B. J., et al. (2011). Is chronic hepatitis B being undertreated in the United States? Journal of Viral Hepatitis, 18, 377–383.PubMedCrossRefGoogle Scholar
  8. 8.
    Mitchell, A. E., Colvin, H. M., & Palmer Beasley, R. (2010). Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology, 51, 729–733.PubMedCrossRefGoogle Scholar
  9. 9.
    Bailey, M. B., Shiau, R., Zola, J., et al. (2011). San Francisco hep B free: A grassroots community coalition to prevent hepatitis B and liver cancer. Journal of Community Health, 36, 538–551.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Chao, S. D., Chang, E. T., Le, P. V., et al. (2009). The Jade Ribbon Campaign: A model program for community outreach and education to prevent liver cancer in Asian Americans. Journal of Immigrant and Minority Health, 11, 281–290.PubMedCrossRefGoogle Scholar
  11. 11.
    US Census Bureau. 2010.Google Scholar
  12. 12.
    Sheu, L. C., Toy, B. C., Kwahk, E., et al. (2010). A model for interprofessional health disparities education: Student-led curriculum on chronic hepatitis B infection. Journal of General Internal Medicine, 25(Suppl 2), S140–S145.PubMedCrossRefGoogle Scholar
  13. 13.
    Wu, C. A., Lin, S. Y., So, S. K., et al. (2007). Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California. Asian Pacific Journal of Cancer Prevention, 8, 127–134.PubMedGoogle Scholar
  14. 14.
    Singal, A., Volk, M., Rakoski, M., et al. (2011). Patient involvement is correlated with higher HCC surveillance in patients with cirrhosis. Journal of Clinical Gastroenterology, 45, 727–732.PubMedCrossRefGoogle Scholar
  15. 15.
    Cohen, C., Caballero, J., Martin, M., et al. (2013). Eradication of hepatitis B: A nationwide community coalition approach to improving vaccination, screening, and linkage to care. Journal of Community Health, 38, 799–804.PubMedCrossRefGoogle Scholar
  16. 16.
    Singal, A. G., Nehra, M., Adams-Huet, B., et al. (2013). Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: Where did surveillance fail? American Journal of Gastroenterology, 108, 425–432.PubMedCrossRefGoogle Scholar
  17. 17.
    Singal, A. G., Yopp, A. C., Gupta, S., et al. (2012). Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prevention Research (Phila), 5, 1124–1130.CrossRefGoogle Scholar
  18. 18.
    Narasimhan, G., Sargios, T. N., Kalakuntla, R., et al. (2006). Treatment rates in patients with chronic hepatitis C after liver biopsy. Journal of Viral Hepatitis, 13, 783–786.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Tresa Zacharias
    • 1
  • Winnie Wang
    • 1
  • Doan Dao
    • 1
  • Helena Wojciechowski
    • 1
  • William M. Lee
    • 1
  • Son Do
    • 1
  • Amit G. Singal
    • 1
  1. 1.Division of Digestive and Liver Diseases, Department of Internal Medicine, Dedman Scholar of Clinical CareUniversity of Texas Southwestern Medical CenterDallasUSA

Personalised recommendations